NCT00011986View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

4,312

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2010

Study Completion Date

January 28, 2013

Conditions
Primary Peritoneal CarcinomaStage III Ovarian CancerStage IV Ovarian Cancer
Interventions
DRUG

Paclitaxel

Given IV

DRUG

Carboplatin

Given IV

DRUG

Gemcitabine Hydrochloride

Given IV

DRUG

Pegylated Liposomal Doxorubicin Hydrochloride

DRUG

Topotecan Hydrochloride

Given IV

PROCEDURE

Therapeutic Conventional Surgery

Undergo surgery

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

SWOG Cancer Research Network

NETWORK

collaborator

Medical Research Council

OTHER_GOV

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00011986 - Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter